Illumina's DNA Patent Dispute With BGI Gets Calif. Jury
A California federal judge empaneled a nine-member jury Friday that will decide Illumina's allegations that Shenzhen-based BGI Genomics Co. Ltd. infringed five DNA sequencing patents after excusing some potential jurors for...To view the full article, register now.
Already a subscriber? Click here to view full article